Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$155 Mln
Revenue (TTM)
$72 Mln
Net Profit (TTM)
$0 Mln
ROE
0.3 %
ROCE
-- %
P/E Ratio
13.9
P/B Ratio
3.6
Industry P/E
54.26
EV/EBITDA
8.8
Div. Yield
0 %
Debt to Equity
0.2
Book Value
$--
EPS
$3.4
Face value
--
Shares outstanding
3,205,985
CFO
$17.45 Mln
EBITDA
$41.04 Mln
Net Profit
$33.03 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pro-Dex (PDEX)
| 32.5 | 15.1 | 32.5 | 2.8 | 45.9 | 13.6 | 29.6 |
|
BSE Sensex*
| -13.5 | -9.9 | -14.0 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Pro-Dex (PDEX)
| -17.7 | 164.7 | 10.2 | -31.5 | -25.1 | 76.5 | 45.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pro-Dex (PDEX)
|
51.0 | 154.8 | 72.1 | 11.3 | 22.4 | 29 | 13.9 | 3.6 |
| 7.8 | 5,176.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 36.1 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 25.9 | 3,989.0 | 2,719.5 | 47.0 | 8.4 | 1.6 | 86.6 | 1.3 | |
| 112.6 | 6,098.9 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 8.9 | |
| 75.7 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.0 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 329.0 | 12,879.6 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.5 | 9.2 | |
| 118.3 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,409.8 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.1 | 2.6 |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers... that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. Address: 2361 McGaw Avenue, Irvine, CA, United States, 92614 Read more
CEO, President, COO & Director
Mr. Richard Lee Van Kirk Jr.
CEO, President, COO & Director
Mr. Richard Lee Van Kirk Jr.
Headquarters
Irvine, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Pro-Dex Inc (PDEX) is $50.99 (NASDAQ) as of 01-Apr-2026 16:00 EDT. Pro-Dex Inc (PDEX) has given a return of 45.92% in the last 3 years.
The P/E ratio of Pro-Dex Inc (PDEX) is 13.91 times as on 31-Mar-2026, a 74 discount to its peers’ median range of 54.26 times.
The P/B ratio of Pro-Dex Inc (PDEX) is 3.60 times as on 31-Mar-2026, a 22 premium to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.29
|
3.99
|
|
2024
|
32.07
|
2.21
|
|
2023
|
9.57
|
2.14
|
|
2022
|
13.02
|
2.34
|
|
2021
|
25.07
|
4.51
|
The 52-week high and low of Pro-Dex Inc (PDEX) are Rs 70.26 and Rs 23.47 as of 02-Apr-2026.
Pro-Dex Inc (PDEX) has a market capitalisation of $ 155 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Pro-Dex Inc (PDEX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$1.87
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.